Drugs / lactobacillus probiotics
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04216459 Comparator | Feb → Nov 2020 | infectious disease with sepsis | Mansoura University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lactobacillus probiotics | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04216459 ↗ |
| Route | Oral | “oral lactobacillus probiotics plus intramuscular cholecalciferol” NCT04216459 ↗ |